Gyre Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.6M | $55.7M | $44.3M |
| FY2022 | $12.5M | $84.8M | $25.2M |
| FY2023 | $38.1M | $116.5M | $33.5M |
| FY2024 | $27.0M | $125.4M | $11.8M |
| FY2025 | $23.9M | $166.1M | $37.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.6M | $55.7M | $44.3M |
| FY2022 | $12.5M | $84.8M | $25.2M |
| FY2023 | $38.1M | $116.5M | $33.5M |
| FY2024 | $27.0M | $125.4M | $11.8M |
| FY2025 | $23.9M | $166.1M | $37.1M |